<table class="table table-striped table-hover" style="width: auto !important; margin-left: auto; margin-right: auto;">
 <thead>
  <tr>
   <th style="text-align:left;"> Characteristics </th>
   <th style="text-align:left;"> Gender </th>
   <th style="text-align:left;"> Ageband </th>
   <th style="text-align:left;"> Datasource TEST </th>
   <th style="text-align:left;"> Datasource TEST2 </th>
  </tr>
 </thead>
<tbody>
  <tr>
   <td style="text-align:left;"> Number of persons who develop a first flare-up episode </td>
   <td style="text-align:left;"> F </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> &lt; 5 </td>
   <td style="text-align:left;"> &lt; 5 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Number of persons who develop a first flare-up episode </td>
   <td style="text-align:left;"> M </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> 0 </td>
   <td style="text-align:left;"> 0 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Number of persons who develop a first flare-up episode </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> 0-17 </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Number of persons who develop a first flare-up episode </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> 18-59 </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Number of persons who develop a first flare-up episode </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> 60+ </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> IR of first flare-up episode, per 1,000 PY (CI 95%) </td>
   <td style="text-align:left;"> F </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> 20841.7 </td>
   <td style="text-align:left;"> 20841.7 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> IR of first flare-up episode, per 1,000 PY (CI 95%) </td>
   <td style="text-align:left;"> M </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> 0 </td>
   <td style="text-align:left;"> 0 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> IR of first flare-up episode, per 1,000 PY (CI 95%) </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> 0-17 </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> IR of first flare-up episode, per 1,000 PY (CI 95%) </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> 18-59 </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> IR of first flare-up episode, per 1,000 PY (CI 95%) </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> 60+ </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Number of persons still in the study 90 days after first flare </td>
   <td style="text-align:left;"> F </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> &lt; 5 </td>
   <td style="text-align:left;"> &lt; 5 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Number of persons still in the study 90 days after first flare </td>
   <td style="text-align:left;"> M </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Number of persons still in the study 90 days after first flare </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> 0-17 </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Number of persons still in the study 90 days after first flare </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> 18-59 </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Number of persons still in the study 90 days after first flare </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> 60+ </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Number of persons who develop a second flare-up episode </td>
   <td style="text-align:left;"> F </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> &lt; 5 </td>
   <td style="text-align:left;"> &lt; 5 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Number of persons who develop a second flare-up episode </td>
   <td style="text-align:left;"> M </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Number of persons who develop a second flare-up episode </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> 0-17 </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Number of persons who develop a second flare-up episode </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> 18-59 </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Number of persons who develop a second flare-up episode </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> 60+ </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> IR of second flare-up episode, per 1,000 PY PY (CI 95%) </td>
   <td style="text-align:left;"> F </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> 59487 </td>
   <td style="text-align:left;"> 59487 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> IR of second flare-up episode, per 1,000 PY PY (CI 95%) </td>
   <td style="text-align:left;"> M </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> IR of second flare-up episode, per 1,000 PY PY (CI 95%) </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> 0-17 </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> IR of second flare-up episode, per 1,000 PY PY (CI 95%) </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> 18-59 </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> IR of second flare-up episode, per 1,000 PY PY (CI 95%) </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> 60+ </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Number of persons still in the study 90 days after second flare </td>
   <td style="text-align:left;"> F </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> &lt; 5 </td>
   <td style="text-align:left;"> &lt; 5 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Number of persons still in the study 90 days after second flare </td>
   <td style="text-align:left;"> M </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Number of persons still in the study 90 days after second flare </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> 0-17 </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Number of persons still in the study 90 days after second flare </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> 18-59 </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Number of persons still in the study 90 days after second flare </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> 60+ </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Number of persons who develop a third flare-up episode </td>
   <td style="text-align:left;"> F </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> &lt; 5 </td>
   <td style="text-align:left;"> &lt; 5 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Number of persons who develop a third flare-up episode </td>
   <td style="text-align:left;"> M </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Number of persons who develop a third flare-up episode </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> 0-17 </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Number of persons who develop a third flare-up episode </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> 18-59 </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Number of persons who develop a third flare-up episode </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> 60+ </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> IR of third flare-up episode, per 1,000 PY PY (CI 95%) </td>
   <td style="text-align:left;"> F </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> 195320.9 </td>
   <td style="text-align:left;"> 195320.9 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> IR of third flare-up episode, per 1,000 PY PY (CI 95%) </td>
   <td style="text-align:left;"> M </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> IR of third flare-up episode, per 1,000 PY PY (CI 95%) </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> 0-17 </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> IR of third flare-up episode, per 1,000 PY PY (CI 95%) </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> 18-59 </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> IR of third flare-up episode, per 1,000 PY PY (CI 95%) </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> 60+ </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
</tbody>
</table>
